tirzepatide cardiovascular outcomes trial results july 2025 compared with semaglutide and 10-year disease risk reduction Effect of Tirzepatide on Cardiovascular

It's not just about the scale reading

Although Qsymia (phentermine + topiramate) is FDA approved for weight loss, taking just topiramate off label still has significant benefits and, having a generic option, is much more affordable, making it a strong candidate for both weight loss and as a maintenance drug to help keep the weight off after a GLP1 regimen

Exendin-4, liraglutide and semaglutide can directly or indirectly stimulate POMC neurons in the ARC, while indirectly inhibiting NPY/AgRP neurons via presynaptic GABAergic neurons [82-84]

- FDA approval secured with shipping via LillyDirect beginning April 6, 2026, followed by retail pharmacy and telehealth availability, positioning Eli Lilly to compete strongly in the oral obesity treatment market

Weight Loss Coaching Benefit from personalized weight loss coaching and guidance tailored to your needs